HEADER CYTOKINE 07-NOV-96 1RH2 TITLE RECOMBINANT HUMAN INTERFERON-ALPHA 2B COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERFERON-ALPHA 2B; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INTERFERON, CYTOKINE, ANTI-VIRAL, IMMUNOMODULATOR, 4 HELIX BUNDLE EXPDTA X-RAY DIFFRACTION MDLTYP CA ATOMS ONLY, CHAIN A, B, C, D, E, F AUTHOR M.R.WALTER REVDAT 3 14-FEB-24 1RH2 1 SEQADV REVDAT 2 24-FEB-09 1RH2 1 VERSN REVDAT 1 12-NOV-97 1RH2 0 JRNL AUTH R.RADHAKRISHNAN,L.J.WALTER,A.HRUZA,P.REICHERT,P.P.TROTTA, JRNL AUTH 2 T.L.NAGABHUSHAN,M.R.WALTER JRNL TITL ZINC MEDIATED DIMER OF HUMAN INTERFERON-ALPHA 2B REVEALED BY JRNL TITL 2 X-RAY CRYSTALLOGRAPHY. JRNL REF STRUCTURE V. 4 1453 1996 JRNL REFN ISSN 0969-2126 JRNL PMID 8994971 JRNL DOI 10.1016/S0969-2126(96)00152-9 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.100 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 27010 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.311 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1326 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3083 REMARK 3 BIN R VALUE (WORKING SET) : 0.3190 REMARK 3 BIN FREE R VALUE : 0.3930 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 787 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 4 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.40 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.49 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.49 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.580 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : RESTRAINTS REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : ZINC.PAR REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : ZINC.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SIX MOLECULES IN THE ASYMMETRIC UNIT REMARK 3 WERE REFINED WITH NCS RESTRAINTS WITH WEIGHT = 30 KCAL/MOL-(A)2 REMARK 3 AND SIGB = 1.5 (A)2 REMARK 4 REMARK 4 1RH2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000176081. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : DEC-95 REMARK 200 TEMPERATURE (KELVIN) : 103 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOLECULAR STRUCTURE CORP., MSC REMARK 200 DATA SCALING SOFTWARE : MSC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31925 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 6.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.24000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MULTIPLE ISOMORPHOUS REMARK 200 REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 40MM REMARK 280 ZINC ACETATE, 30MM CACODYLATE, PH 5.6; MACRO SEEDING WAS REMARK 280 PERFORMED TO GET REASONABLE SIZE CRYSTALS., MACROSEEDING REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.75000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE DISULFIDE BOND BETWEEN CYS 1 AND CYS 98 IS NOT REMARK 400 OBSERVED. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 1 REMARK 465 ASP A 2 REMARK 465 LEU A 3 REMARK 465 PRO A 4 REMARK 465 GLN A 5 REMARK 465 VAL A 103 REMARK 465 GLY A 104 REMARK 465 VAL A 105 REMARK 465 THR A 106 REMARK 465 GLU A 107 REMARK 465 THR A 108 REMARK 465 PRO A 109 REMARK 465 LEU A 110 REMARK 465 MET A 111 REMARK 465 SER A 160 REMARK 465 LEU A 161 REMARK 465 ARG A 162 REMARK 465 SER A 163 REMARK 465 LYS A 164 REMARK 465 GLU A 165 REMARK 465 CYS B 1 REMARK 465 ASP B 2 REMARK 465 LEU B 3 REMARK 465 PRO B 4 REMARK 465 GLN B 5 REMARK 465 THR B 6 REMARK 465 HIS B 7 REMARK 465 ASN B 45 REMARK 465 GLN B 46 REMARK 465 PHE B 47 REMARK 465 GLN B 48 REMARK 465 LYS B 49 REMARK 465 VAL B 103 REMARK 465 GLY B 104 REMARK 465 VAL B 105 REMARK 465 THR B 106 REMARK 465 GLU B 107 REMARK 465 THR B 108 REMARK 465 PRO B 109 REMARK 465 LEU B 110 REMARK 465 MET B 111 REMARK 465 GLU B 159 REMARK 465 SER B 160 REMARK 465 LEU B 161 REMARK 465 ARG B 162 REMARK 465 SER B 163 REMARK 465 LYS B 164 REMARK 465 GLU B 165 REMARK 465 CYS C 1 REMARK 465 ASP C 2 REMARK 465 LEU C 3 REMARK 465 PRO C 4 REMARK 465 GLN C 5 REMARK 465 THR C 6 REMARK 465 HIS C 7 REMARK 465 SER C 8 REMARK 465 LEU C 9 REMARK 465 GLY C 10 REMARK 465 ASN C 45 REMARK 465 GLN C 46 REMARK 465 PHE C 47 REMARK 465 GLN C 48 REMARK 465 LYS C 49 REMARK 465 ASN C 93 REMARK 465 ASP C 94 REMARK 465 LEU C 95 REMARK 465 GLU C 96 REMARK 465 ALA C 97 REMARK 465 CYS C 98 REMARK 465 VAL C 99 REMARK 465 ILE C 100 REMARK 465 GLN C 101 REMARK 465 GLY C 102 REMARK 465 VAL C 103 REMARK 465 GLY C 104 REMARK 465 VAL C 105 REMARK 465 THR C 106 REMARK 465 GLU C 107 REMARK 465 THR C 108 REMARK 465 PRO C 109 REMARK 465 LEU C 110 REMARK 465 MET C 111 REMARK 465 LEU C 157 REMARK 465 GLN C 158 REMARK 465 GLU C 159 REMARK 465 SER C 160 REMARK 465 LEU C 161 REMARK 465 ARG C 162 REMARK 465 SER C 163 REMARK 465 LYS C 164 REMARK 465 GLU C 165 REMARK 465 CYS D 1 REMARK 465 ASP D 2 REMARK 465 LEU D 3 REMARK 465 PRO D 4 REMARK 465 GLN D 5 REMARK 465 THR D 6 REMARK 465 HIS D 7 REMARK 465 ASN D 45 REMARK 465 GLN D 46 REMARK 465 PHE D 47 REMARK 465 GLN D 48 REMARK 465 LYS D 49 REMARK 465 ALA D 97 REMARK 465 CYS D 98 REMARK 465 VAL D 99 REMARK 465 ILE D 100 REMARK 465 GLN D 101 REMARK 465 GLY D 102 REMARK 465 VAL D 103 REMARK 465 GLY D 104 REMARK 465 VAL D 105 REMARK 465 THR D 106 REMARK 465 GLU D 107 REMARK 465 THR D 108 REMARK 465 PRO D 109 REMARK 465 LEU D 110 REMARK 465 MET D 111 REMARK 465 GLU D 159 REMARK 465 SER D 160 REMARK 465 LEU D 161 REMARK 465 ARG D 162 REMARK 465 SER D 163 REMARK 465 LYS D 164 REMARK 465 GLU D 165 REMARK 465 CYS E 1 REMARK 465 ASP E 2 REMARK 465 LEU E 3 REMARK 465 PRO E 4 REMARK 465 GLN E 5 REMARK 465 THR E 6 REMARK 465 HIS E 7 REMARK 465 ASN E 45 REMARK 465 GLN E 46 REMARK 465 PHE E 47 REMARK 465 GLN E 48 REMARK 465 LYS E 49 REMARK 465 CYS E 98 REMARK 465 VAL E 99 REMARK 465 ILE E 100 REMARK 465 GLN E 101 REMARK 465 GLY E 102 REMARK 465 VAL E 103 REMARK 465 GLY E 104 REMARK 465 VAL E 105 REMARK 465 THR E 106 REMARK 465 GLU E 107 REMARK 465 THR E 108 REMARK 465 PRO E 109 REMARK 465 LEU E 110 REMARK 465 MET E 111 REMARK 465 GLU E 159 REMARK 465 SER E 160 REMARK 465 LEU E 161 REMARK 465 ARG E 162 REMARK 465 SER E 163 REMARK 465 LYS E 164 REMARK 465 GLU E 165 REMARK 465 CYS F 1 REMARK 465 ASP F 2 REMARK 465 LEU F 3 REMARK 465 PRO F 4 REMARK 465 GLN F 5 REMARK 465 THR F 6 REMARK 465 HIS F 7 REMARK 465 SER F 8 REMARK 465 LEU F 9 REMARK 465 GLY F 44 REMARK 465 ASN F 45 REMARK 465 GLN F 46 REMARK 465 PHE F 47 REMARK 465 GLN F 48 REMARK 465 LYS F 49 REMARK 465 ALA F 50 REMARK 465 GLU F 51 REMARK 465 ASN F 93 REMARK 465 ASP F 94 REMARK 465 LEU F 95 REMARK 465 GLU F 96 REMARK 465 ALA F 97 REMARK 465 CYS F 98 REMARK 465 VAL F 99 REMARK 465 ILE F 100 REMARK 465 GLN F 101 REMARK 465 GLY F 102 REMARK 465 VAL F 103 REMARK 465 GLY F 104 REMARK 465 VAL F 105 REMARK 465 THR F 106 REMARK 465 GLU F 107 REMARK 465 THR F 108 REMARK 465 PRO F 109 REMARK 465 LEU F 110 REMARK 465 MET F 111 REMARK 465 LEU F 157 REMARK 465 GLN F 158 REMARK 465 GLU F 159 REMARK 465 SER F 160 REMARK 465 LEU F 161 REMARK 465 ARG F 162 REMARK 465 SER F 163 REMARK 465 LYS F 164 REMARK 465 GLU F 165 DBREF 1RH2 A 1 165 UNP P01563 IFNA2_HUMAN 24 188 DBREF 1RH2 B 1 165 UNP P01563 IFNA2_HUMAN 24 188 DBREF 1RH2 C 1 165 UNP P01563 IFNA2_HUMAN 24 188 DBREF 1RH2 D 1 165 UNP P01563 IFNA2_HUMAN 24 188 DBREF 1RH2 E 1 165 UNP P01563 IFNA2_HUMAN 24 188 DBREF 1RH2 F 1 165 UNP P01563 IFNA2_HUMAN 24 188 SEQADV 1RH2 ARG A 23 UNP P01563 LYS 46 CONFLICT SEQADV 1RH2 ASN A 112 UNP P01563 LYS 135 CONFLICT SEQADV 1RH2 ARG B 23 UNP P01563 LYS 46 CONFLICT SEQADV 1RH2 ASN B 112 UNP P01563 LYS 135 CONFLICT SEQADV 1RH2 ARG C 23 UNP P01563 LYS 46 CONFLICT SEQADV 1RH2 ASN C 112 UNP P01563 LYS 135 CONFLICT SEQADV 1RH2 ARG D 23 UNP P01563 LYS 46 CONFLICT SEQADV 1RH2 ASN D 112 UNP P01563 LYS 135 CONFLICT SEQADV 1RH2 ARG E 23 UNP P01563 LYS 46 CONFLICT SEQADV 1RH2 ASN E 112 UNP P01563 LYS 135 CONFLICT SEQADV 1RH2 ARG F 23 UNP P01563 LYS 46 CONFLICT SEQADV 1RH2 ASN F 112 UNP P01563 LYS 135 CONFLICT SEQRES 1 A 165 CYS ASP LEU PRO GLN THR HIS SER LEU GLY SER ARG ARG SEQRES 2 A 165 THR LEU MET LEU LEU ALA GLN MET ARG ARG ILE SER LEU SEQRES 3 A 165 PHE SER CYS LEU LYS ASP ARG HIS ASP PHE GLY PHE PRO SEQRES 4 A 165 GLN GLU GLU PHE GLY ASN GLN PHE GLN LYS ALA GLU THR SEQRES 5 A 165 ILE PRO VAL LEU HIS GLU MET ILE GLN GLN ILE PHE ASN SEQRES 6 A 165 LEU PHE SER THR LYS ASP SER SER ALA ALA TRP ASP GLU SEQRES 7 A 165 THR LEU LEU ASP LYS PHE TYR THR GLU LEU TYR GLN GLN SEQRES 8 A 165 LEU ASN ASP LEU GLU ALA CYS VAL ILE GLN GLY VAL GLY SEQRES 9 A 165 VAL THR GLU THR PRO LEU MET ASN GLU ASP SER ILE LEU SEQRES 10 A 165 ALA VAL ARG LYS TYR PHE GLN ARG ILE THR LEU TYR LEU SEQRES 11 A 165 LYS GLU LYS LYS TYR SER PRO CYS ALA TRP GLU VAL VAL SEQRES 12 A 165 ARG ALA GLU ILE MET ARG SER PHE SER LEU SER THR ASN SEQRES 13 A 165 LEU GLN GLU SER LEU ARG SER LYS GLU SEQRES 1 B 165 CYS ASP LEU PRO GLN THR HIS SER LEU GLY SER ARG ARG SEQRES 2 B 165 THR LEU MET LEU LEU ALA GLN MET ARG ARG ILE SER LEU SEQRES 3 B 165 PHE SER CYS LEU LYS ASP ARG HIS ASP PHE GLY PHE PRO SEQRES 4 B 165 GLN GLU GLU PHE GLY ASN GLN PHE GLN LYS ALA GLU THR SEQRES 5 B 165 ILE PRO VAL LEU HIS GLU MET ILE GLN GLN ILE PHE ASN SEQRES 6 B 165 LEU PHE SER THR LYS ASP SER SER ALA ALA TRP ASP GLU SEQRES 7 B 165 THR LEU LEU ASP LYS PHE TYR THR GLU LEU TYR GLN GLN SEQRES 8 B 165 LEU ASN ASP LEU GLU ALA CYS VAL ILE GLN GLY VAL GLY SEQRES 9 B 165 VAL THR GLU THR PRO LEU MET ASN GLU ASP SER ILE LEU SEQRES 10 B 165 ALA VAL ARG LYS TYR PHE GLN ARG ILE THR LEU TYR LEU SEQRES 11 B 165 LYS GLU LYS LYS TYR SER PRO CYS ALA TRP GLU VAL VAL SEQRES 12 B 165 ARG ALA GLU ILE MET ARG SER PHE SER LEU SER THR ASN SEQRES 13 B 165 LEU GLN GLU SER LEU ARG SER LYS GLU SEQRES 1 C 165 CYS ASP LEU PRO GLN THR HIS SER LEU GLY SER ARG ARG SEQRES 2 C 165 THR LEU MET LEU LEU ALA GLN MET ARG ARG ILE SER LEU SEQRES 3 C 165 PHE SER CYS LEU LYS ASP ARG HIS ASP PHE GLY PHE PRO SEQRES 4 C 165 GLN GLU GLU PHE GLY ASN GLN PHE GLN LYS ALA GLU THR SEQRES 5 C 165 ILE PRO VAL LEU HIS GLU MET ILE GLN GLN ILE PHE ASN SEQRES 6 C 165 LEU PHE SER THR LYS ASP SER SER ALA ALA TRP ASP GLU SEQRES 7 C 165 THR LEU LEU ASP LYS PHE TYR THR GLU LEU TYR GLN GLN SEQRES 8 C 165 LEU ASN ASP LEU GLU ALA CYS VAL ILE GLN GLY VAL GLY SEQRES 9 C 165 VAL THR GLU THR PRO LEU MET ASN GLU ASP SER ILE LEU SEQRES 10 C 165 ALA VAL ARG LYS TYR PHE GLN ARG ILE THR LEU TYR LEU SEQRES 11 C 165 LYS GLU LYS LYS TYR SER PRO CYS ALA TRP GLU VAL VAL SEQRES 12 C 165 ARG ALA GLU ILE MET ARG SER PHE SER LEU SER THR ASN SEQRES 13 C 165 LEU GLN GLU SER LEU ARG SER LYS GLU SEQRES 1 D 165 CYS ASP LEU PRO GLN THR HIS SER LEU GLY SER ARG ARG SEQRES 2 D 165 THR LEU MET LEU LEU ALA GLN MET ARG ARG ILE SER LEU SEQRES 3 D 165 PHE SER CYS LEU LYS ASP ARG HIS ASP PHE GLY PHE PRO SEQRES 4 D 165 GLN GLU GLU PHE GLY ASN GLN PHE GLN LYS ALA GLU THR SEQRES 5 D 165 ILE PRO VAL LEU HIS GLU MET ILE GLN GLN ILE PHE ASN SEQRES 6 D 165 LEU PHE SER THR LYS ASP SER SER ALA ALA TRP ASP GLU SEQRES 7 D 165 THR LEU LEU ASP LYS PHE TYR THR GLU LEU TYR GLN GLN SEQRES 8 D 165 LEU ASN ASP LEU GLU ALA CYS VAL ILE GLN GLY VAL GLY SEQRES 9 D 165 VAL THR GLU THR PRO LEU MET ASN GLU ASP SER ILE LEU SEQRES 10 D 165 ALA VAL ARG LYS TYR PHE GLN ARG ILE THR LEU TYR LEU SEQRES 11 D 165 LYS GLU LYS LYS TYR SER PRO CYS ALA TRP GLU VAL VAL SEQRES 12 D 165 ARG ALA GLU ILE MET ARG SER PHE SER LEU SER THR ASN SEQRES 13 D 165 LEU GLN GLU SER LEU ARG SER LYS GLU SEQRES 1 E 165 CYS ASP LEU PRO GLN THR HIS SER LEU GLY SER ARG ARG SEQRES 2 E 165 THR LEU MET LEU LEU ALA GLN MET ARG ARG ILE SER LEU SEQRES 3 E 165 PHE SER CYS LEU LYS ASP ARG HIS ASP PHE GLY PHE PRO SEQRES 4 E 165 GLN GLU GLU PHE GLY ASN GLN PHE GLN LYS ALA GLU THR SEQRES 5 E 165 ILE PRO VAL LEU HIS GLU MET ILE GLN GLN ILE PHE ASN SEQRES 6 E 165 LEU PHE SER THR LYS ASP SER SER ALA ALA TRP ASP GLU SEQRES 7 E 165 THR LEU LEU ASP LYS PHE TYR THR GLU LEU TYR GLN GLN SEQRES 8 E 165 LEU ASN ASP LEU GLU ALA CYS VAL ILE GLN GLY VAL GLY SEQRES 9 E 165 VAL THR GLU THR PRO LEU MET ASN GLU ASP SER ILE LEU SEQRES 10 E 165 ALA VAL ARG LYS TYR PHE GLN ARG ILE THR LEU TYR LEU SEQRES 11 E 165 LYS GLU LYS LYS TYR SER PRO CYS ALA TRP GLU VAL VAL SEQRES 12 E 165 ARG ALA GLU ILE MET ARG SER PHE SER LEU SER THR ASN SEQRES 13 E 165 LEU GLN GLU SER LEU ARG SER LYS GLU SEQRES 1 F 165 CYS ASP LEU PRO GLN THR HIS SER LEU GLY SER ARG ARG SEQRES 2 F 165 THR LEU MET LEU LEU ALA GLN MET ARG ARG ILE SER LEU SEQRES 3 F 165 PHE SER CYS LEU LYS ASP ARG HIS ASP PHE GLY PHE PRO SEQRES 4 F 165 GLN GLU GLU PHE GLY ASN GLN PHE GLN LYS ALA GLU THR SEQRES 5 F 165 ILE PRO VAL LEU HIS GLU MET ILE GLN GLN ILE PHE ASN SEQRES 6 F 165 LEU PHE SER THR LYS ASP SER SER ALA ALA TRP ASP GLU SEQRES 7 F 165 THR LEU LEU ASP LYS PHE TYR THR GLU LEU TYR GLN GLN SEQRES 8 F 165 LEU ASN ASP LEU GLU ALA CYS VAL ILE GLN GLY VAL GLY SEQRES 9 F 165 VAL THR GLU THR PRO LEU MET ASN GLU ASP SER ILE LEU SEQRES 10 F 165 ALA VAL ARG LYS TYR PHE GLN ARG ILE THR LEU TYR LEU SEQRES 11 F 165 LYS GLU LYS LYS TYR SER PRO CYS ALA TRP GLU VAL VAL SEQRES 12 F 165 ARG ALA GLU ILE MET ARG SER PHE SER LEU SER THR ASN SEQRES 13 F 165 LEU GLN GLU SER LEU ARG SER LYS GLU HET ZN A1204 1 HET ZN B1201 1 HET ZN C1203 1 HET ZN E1202 1 HETNAM ZN ZINC ION FORMUL 7 ZN 4(ZN 2+) CRYST1 62.400 75.500 148.200 90.00 90.80 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016026 0.000000 0.000224 0.00000 SCALE2 0.000000 0.013245 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006748 0.00000 MTRIX1 1 -0.998000 -0.045000 -0.036000 86.80400 1 MTRIX2 1 0.042000 -0.128000 -0.991000 124.76500 1 MTRIX3 1 0.040000 -0.991000 0.129000 109.34000 1 MTRIX1 2 -0.984000 -0.105000 -0.142000 120.79500 1 MTRIX2 2 0.058000 -0.952000 0.302000 60.64400 1 MTRIX3 2 -0.167000 0.289000 0.943000 -39.30100 1 MTRIX1 3 0.997000 0.067000 0.025000 19.05000 1 MTRIX2 3 -0.017000 -0.126000 0.992000 -25.90300 1 MTRIX3 3 0.070000 -0.990000 -0.125000 90.21100 1 MTRIX1 4 0.991000 0.119000 0.055000 -7.07800 1 MTRIX2 4 -0.119000 0.993000 0.002000 -5.13700 1 MTRIX3 4 -0.055000 -0.009000 0.998000 -72.18800 1 MTRIX1 5 -0.971000 -0.114000 -0.209000 104.10800 1 MTRIX2 5 0.224000 -0.142000 -0.964000 105.49100 1 MTRIX3 5 0.080000 -0.983000 0.164000 29.86300 1